2021-1-25 17:10 |
Continue reading at Coinspeaker origin »
|
Moderna has got nearly $1 billion in support from the U.S. government so far to support the development of the COVID-19 vaccine. The biotech firm is conducting its last-stage trials. MRNA stock is up.
2020-7-28 13:37 | |
|
|
Coinspeaker BioNTech (BNTX) Stock Down 2% though Company Receives Approval for COVID-19 Vaccine TrialsShanghai Fosun Pharmaceutical Industrial Development received the acceptance notice of clinical trial application for the COVID-19 vaccine candidate BNT162b1 created by BioNTech.
2020-7-17 22:15 | |
|
|
Coinspeaker AZN Stock Up 2%, AstraZeneca Gets $1B for Oxford University’s Coronavirus VaccineThe U. S. Biomedical Advanced Research and Development Authority has given AstraZeneca more than $1 billion in funding for the coronavirus vaccine.
2020-5-21 20:21 | |
|
|
Coinspeaker MRNA Stock Hikes 15% as Moderna Gets $483M Funding to Develop Coronavirus VaccineAfter Moderna announced it received $483 million in federal funding to speed up the development of the coronavirus vaccine, MRNA stock hiked 15%.
2020-4-19 16:31 | |
|
|
Coinspeaker Coronavirus Stocks: Why Gilead Sciences, Moderna, Inovio Pharmaceuticals, Novavax RoseWhile tech shares are suffering drops, coronavirus stocks are soaring, The pharma companies are actively working on the development of a new vaccine.
2020-2-28 21:24 | |
|
|
A British scientist has discovered a possible coronavirus vaccine with a significantly faster development time. The vaccine will go to animal trials next week. The post Dow Jones Leaps on Potential Coronavirus Vaccine Breakthrough appeared first on CCN.com
2020-2-5 13:39 | |
|
|
A British scientist has discovered a possible coronavirus vaccine with a significantly faster development time. The vaccine will go to animal trials next week. The post Dow Futures Leap on Potential Coronavirus Vaccine Breakthrough appeared first on CCN.com
2020-2-5 13:39 | |
|
|